What are the Epidemiological Benefits of Hydroxyurea?
From an epidemiological perspective, the use of hydroxyurea in sickle cell disease has significant public health benefits. It can decrease morbidity and mortality rates, improve quality of life, and reduce healthcare costs associated with hospitalizations and emergency room visits. By preventing complications, hydroxyurea also allows patients to maintain a more stable and productive life.
